1
|
Senoga A, Wasike R, Ali Mwanzi S, Mutebi M. Quality of life of patients one year after breast-conserving surgery versus modified radical mastectomy for early breast cancer: a Kenyan tertiary hospital five-year review. Pan Afr Med J 2023; 46:69. [PMID: 38282779 PMCID: PMC10822102 DOI: 10.11604/pamj.2023.46.69.39151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 10/09/2023] [Indexed: 01/30/2024] Open
Abstract
Introduction Breast conserving surgery (BCS) followed by radiotherapy (BCT) and modified radical mastectomy (MRM) are the most common surgical techniques utilized in treatment of early breast cancer (EBC) with similar overall survival and recurrence rates. Western literature suggests that these treatments impact the quality of life (QOL) of patients variably. There are no comparison studies on these treatments as per patient's QOL in East Africa. The objectives were to compare the QOL of patients with EBC at least one year after BCT or MRM and assess the factors that affect this QOL. Methods this was a cross-sectional study conducted at Aga Khan University Hospital-Nairobi (AKUHN). Eligible female patients with EBC who had undergone either BCT or MRM between January 2013 and December 2018 were invited to fill out European Organization for the Treatment and Research of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30). Data on participant demographics and clinical information was also obtained. Average scores for each aspect of QOL were obtained and overall means for each surgical treatment were compared. Linear regression was done to assess the factors that affected this QOL. Results forty-two patients had BCS/BCT and 39 had MRM. Patients who had undergone BCS/BCT had a better overall QOL than those who had undergone MRM (p=0.0149). Multivariate analysis revealed that five years from time of surgery, level of education and diabetes mellitus significantly (p<0.05) affected the QOL of these patients. Conclusion after one year from surgery for EBC, patients who had undergone BCS/BCT had a better QOL as compared to MRM.
Collapse
Affiliation(s)
- Andrew Senoga
- Department of Surgery, Aga Khan University Hospital, Nairobi, Kenya
| | - Ronald Wasike
- Department of Surgery, Masinde Muliro University Medical School, Kakamega, Kenya
| | - Sitna Ali Mwanzi
- Medical Oncology, Cancer Treatment Center, Kenyatta National Hospital, Nairobi, Kenya
| | - Miriam Mutebi
- Department of Surgery, Aga Khan University Hospital, Nairobi, Kenya
| |
Collapse
|
2
|
Rubagumya F, Makori K, Borges H, Mwanzi SA, Karim S, Msadabwe SC, Dharsee NJ, Mutebi MC, Hopman WM, Vanderpuye VD, Ka S, Ndlovu N, Hammad N, Booth CM. Choosing Wisely Africa: Insights from the front-lines of clinical care. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.e18835] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e18835 Background: A multidisciplinary Task Force of African oncologists and patient representatives published the Choosing Wisely Africa (CWA) recommendations in 2020. These recommendations identified low-value, unnecessary, or harmful practices that are frequently used in Sub-Saharan Africa (SSA). We describe agreement and concordance with the recommendations from front-line oncologists across SSA. Methods: A self-administered electronic survey was distributed to members of the African Organization for Research & Training in Cancer and oncology groups within SSA using a hierarchical snowball method. The survey captured information about awareness of CWA, agreement with recommendations, and concordance with clinical practice. Descriptive statistics were used to summarize study results. Results: 49 individuals responded to the survey; 61% (30/49) were female and 59% (29/49) were clinical oncologists. Respondents represented 14 countries in SSA; 69% (34/49) practiced exclusively in the public system. Only 43% (21/49) were aware of the CWA list and 90% (44/49) agreed it would be helpful if the list was displayed in their clinic. There was generally high agreement (Table) with the recommendations (range 84-98%); highest agreement related to staging/defining treatment intent (98%). The proportion of oncologists who implemented these recommendations in routine practice was somewhat lower (range 68-100%). Lowest rates of concordance related to: use of shorter schedules of radiotherapy (68%). Conclusions: While most frontline SSA oncologists agree with CWA recommendations, efforts are needed to disseminate the list. Agreement with the recommendations is high but there are gaps in implementation in routine practice. Further work is required to understand barriers and enablers of implementation.[Table: see text]
Collapse
Affiliation(s)
| | - Kevin Makori
- Ocean Road Cancer Institute, Dar es Salaam, Tanzania, United Republic of
| | | | | | - Safiya Karim
- Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
| | | | | | | | - Wilma M. Hopman
- Department of Public Health Sciences-Queen's University, Kingston, ON, Canada
| | | | - Sidy Ka
- Cheikh Anta Diop University, Dakar, Senegal
| | | | - Nazik Hammad
- Department of Oncology, Cancer Center of Southeastern Ontario, Queen's University, Kingston, ON, Canada
| | | |
Collapse
|
3
|
Mutebi MC, Aryeetey NA, Carson LM, Mwanzi SA, Lombe DC, Woldetsadik ES, Msadabwe SC, Lasebikan N, Mohamed Z, Ramogola-Masire D, Alemu HK, Jalink M, Jagsi R, Vanderpuye VD, Hammad N. Challenges faced by female oncologists in sub-Saharan Africa. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.11001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11001 Background: Recent articles by ASCO and ESMO have identified challenges facing female oncologists in western contexts. The challenges female oncologists face in sub-Saharan Africa (SSA) have yet to be explored. This study was launched by the AORTIC Education and Training Committee to determine the most common and substantial challenges faced by female oncologists in SSA and identify potential solutions. Methods: A diverse panel of 32 female oncologists from 20 countries in SSA was recruited through professional and personal networks. Following an initial meeting to review terminology, a modified three-round Delphi process took place. Participants iteratively reviewed a list of previously identified challenges facing women in oncology in SSA and identified new challenges. The survey was conducted via REDCap, a secure-web-based software platform. Participants reflected on personal experiences or those of colleagues, and were asked to indicate their agreement with each listed challenge, as well as propose solutions. Descriptive statistics identified the most common challenges. Following the third survey, a focus group was held to enrich study data. A thematic analysis is being conducted on the focus group transcript to identify key themes, and a subsequent modified Delphi process is being executed to build consensus around potential solutions to identified challenges. Results: Response rates for the 3 modified Delphi rounds were 66%, 66%, and 53%. The challenge with the greatest agreement was, “pressure to maintain a work-family life balance and meet social obligations”. These were felt to be unique to women in SSA due to an extended family network with several responsibilities beyond the nuclear family. The next two top-scored challenges were “lack of female support and networks”, and “micro-aggressions” (Table). Conclusions: Female oncologists in SSA experience many of the challenges that have been previously identified by similar studies in other regions, with different degrees of perceived importance. Some challenges have a different lived experience for female oncologists in SSA. The second part of this study will include thematic analysis of the recent focus group and explore potential solutions to mitigate these challenges, which will add insight and potential paths forward to optimizing a diverse workforce in SSA.[Table: see text]
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Nwamaka Lasebikan
- Department of Radiation Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria
| | | | | | | | | | - Reshma Jagsi
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
| | | | - Nazik Hammad
- Department of Oncology, Cancer Center of Southeastern Ontario, Queen's University, Kingston, ON, Canada
| |
Collapse
|